Saturday, December 14, 2019

PaceyCuff Use for Parkinsons Disease

Incontinence in Neurological Disorders Parkinson's Disease-  Neurogenic Bladder

The Problem:

    Patients with advancing Parkinson's Syndrome have several issues affecting the bladder function. With age in a normal population the incidence of incontinence gets higher in proportion to age of the individual. The incidence increases from 11%overall to 31 % in older men.

    The prostate enlarges over time and often restricts urine flow in the elderly. This results in
 increasing amounts of retention of urine in the bladder and resulting overflow incontinence with stress. The treatment of this cause is usually some method of removing the offending prostate tissue to increase flow. This does allow better emptying of the bladder but in itself can result in incontinence in only 1% of patients normally. 

   Parkinson's Neurogenic bladder is failure of the neurological control mechanisms.

Management with a PaceyCuff device will depend on the exact applications which must be thought out and executed with care.


Fig.1       PaceyCuff Ultra (tm)



Fig. 2     PaceyCuff Guard clothing protector

Known usage:

   1. PaceyCuff specific use for ambulation of the patient for physical therapy or xray.
   2. PaceyCuff  specific use for social outings.
   3. PaceyCuff use for prevention of bed wetting which requires a specific protocol for regular                     release. 






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































\

No comments:

Post a Comment